Skip to main content

View Digital Edition
Perspective
Ipilimumab: A New Era in Metastatic Melanoma Management
Timothy G. Tyler, PharmD, FCSHP, FHOPA
Read More
FDA Updates
Reversible Posterior Leukoencephalopathy Syndrome Secondary to Bevacizumab
Diana Pinto, PharmD, William Kernan, PharmD, BCPS, James Hoffman, MD, Mohammed Ibrahim, PharmD, CRPH, BCOP, BCPS, Bruno Bastos, MD
Read More
Original Research
The Risk of Neurotoxicity with Concomitant Use of Aprepitant and Ifosfamide
Anthony Jarkowski III, PharmD, BCOP, Austin Miller, PhD, Tammy A. Hecke, RN, BSN, Leona Blustein, PharmD, Michael K.K. Wong, MD, PhD, FRCPC
Read More
Practical Issues in Pharmacy Management
Implementation of a Pharmacist-Managed Interdisciplinary Oral Chemotherapy Program in a Community Cancer Center
Robert Mancini, PharmD, BCOP, FHOPA, Lindsay M. Kaster, PharmD, Brian Vu, PharmD, Jessie Modlin, PharmD, David B. Wilson, RPh
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More

Results 1 - 5 of 5